Stay on cancer drug licence may harm public: Natco Pharma
September 5th, 2012 - 12:08 am ICT by IANS
Chennai, Sep 4 (IANS) Public interest would be seriously affected if the order of compulsory licence issued in favour of Natco Pharma Ltd to make and sell the cancer drug ... Read more...
Posted in Business |
Public not to be hit if Natco Pharma licence cancelled: Bayer
September 3rd, 2012 - 11:08 pm ICT by IANS
Chennai, Sep 3 (IANS) The cancellation of a compulsory licence to Hyderabad-based Natco Pharma Ltd to make and sell the generic equivalent of cancer drug Nexavar will not impact public ... Read more...
Posted in Health |
Cancer drug: Natco Pharma told to file reply by Aug 25
August 21st, 2012 - 9:05 pm ICT by IANS
Chennai, Aug 21 (IANS) The Intellectual Property Appellate Board (IPAB) Tuesday asked the Hyderabad-based Natco Pharma to reply by Aug 25 on Bayer Corp's plea against the issuance of licence ... Read more...
Posted in Business |
Judicial review of Patent Act amendment sought
April 12th, 2008 - 8:26 pm ICT by admin
Bangalore, April 12 (IANS) An Indian judge Saturday sought a review of the Indian Patent Act, 1970, which was amended in March 2005 to comply with the World Trade Organisation (WTO) regulations, ... Read more...
Posted in Uncategorized |